Oliviero James F III — SEC Form 4 filings
SEC reporting owner CIK 1434718. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-02 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 899,455 shares, $3,286,266 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 602,167 shares @ $3.87 ($2,330,386) in Checkpoint Therapeutics, Inc., filed 2024-12-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Checkpoint Therapeutics, Inc. (CKPT) | CEO, President and Director, Director | 10 | — | 8 legs · 899,455 sh · $3,286,266 | 8 |
| Nuvectis Pharma, Inc. (NVCT) | Director | 3 | — | — | 3 |
Form 4 filings — Oliviero James F III
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Nuvectis Pharma, Inc. (NVCT) | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Nuvectis Pharma, Inc. (NVCT) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2025-05-30 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Code (U): 3,759,929 | EDGAR |
| 2025-04-03 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 15,090 @ $4.04 | EDGAR |
| 2025-02-11 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 9,233 @ $3.41 · Sale (S): 10,331 @ $3.15 | EDGAR |
| 2025-01-31 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 1,500,000 @ $0 | EDGAR |
| 2024-12-20 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 602,167 @ $3.87 · Sale (S): 220,230 @ $3.38 · Gift (G): 900,000 @ $0 | EDGAR |
| 2024-12-17 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 2,077,700 @ $0 | EDGAR |
| 2024-06-28 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 24,610 @ $2.05 · Gift (G): 37,890 @ $0 | EDGAR |
| 2024-06-13 | 4 | Nuvectis Pharma, Inc. (NVCT) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2024-05-24 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 1,660,000 @ $0 | EDGAR |
| 2024-03-01 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 5,894 @ $2.06 · Gift (G): 9,056 @ $0 | EDGAR |
| 2024-02-02 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Sale (S): 11,900 @ $2.01 · Gift (G): 12,950 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1434718 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →